Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Clinical trial NCT03520647 · RECRUITING

Trial details

NCT number: NCT03520647
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Aplastic Anemia (SAA)Hypo-Plastic Myelodysplastic Syndrome (MDS)Paroxysmal Nocturnal Hemoglobinuria (PNH)

Start date: 2019-02-19
Primary completion: 2027-06-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.